Stock 4523 EISAI CO., LTD.
Add to a list

Governance Eisai Co., Ltd.

Stocks

4523

JP3160400002

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 12:00:00 12/06/2026 pm IST 		5-day change 1st Jan Change
3,780.00 JPY +1.53% Intraday chart for Eisai Co., Ltd. +0.13% -18.88%
11/06 Beren Therapeutics P.B.C. announced that it has received $245 million in funding from Eisai Co., Ltd., The Founders Fund, LLC, Wellington Partners Advisory AG, Narya Capital, JIC Venture Growth Investments Co., Ltd. and other investors CI
04/06 Eisai Co., Ltd. Announces Issuance of Unsecured Straight Bonds CI

Executive Committee: Eisai Co., Ltd.

Manager
Positions heldSince
Haruo Naito

Haruo Naito

78 year

Chief Executive Officer 01/06/2003
Katsutoshi Ido

Katsutoshi Ido

47 year

Chief Tech/Sci/R&D Officer 01/04/2025
Shinichi Sagawa

Shinichi Sagawa

Comptroller/Controller/Auditor -
Public Communications Contact -
Shin Kato

Shin Kato

54 year

Compliance Officer 01/06/2024
General Counsel 01/06/2024
Akiko Nakahama

Akiko Nakahama

57 year

Chief Tech/Sci/R&D Officer 01/04/2025
Makoto Hoketsu

Makoto Hoketsu

57 year

Chief Tech/Sci/R&D Officer 01/04/2023
Teruyuki Masaka

Teruyuki Masaka

48 year

Human Resources Officer 17/06/2022
Public Communications Contact 17/06/2022
Keisuke Naito

Keisuke Naito

37 year

Chief Operating Officer 14/06/2024
Lynn Kramer

Lynn Kramer

75 year

Chief Tech/Sci/R&D Officer 01/04/2016
Terushige Iike

Terushige Iike

62 year

Comptroller/Controller/Auditor 01/04/2025
Takuya Oyama

Takuya Oyama

48 year

Director of Finance/CFO 01/01/2026
Investor Relations Contact 01/08/2025

Composition of the Board of Directors: Eisai Co., Ltd.

Director
CommitteesSince
Fumihiko Ike

Fumihiko Ike

74 year

Nominating Committee 01/06/2023
Compensation Committee Chair 01/06/2023
Governance Committee Chair 01/06/2023
Ryoko Ueda

Ryoko Ueda

53 year

Compensation Committee 01/06/2023
Nominating Committee 01/06/2023
Audit Committee 01/06/2025
Governance Committee 01/06/2025
Clive Richard Thornley

Clive Richard Thornley

61 year

Governance Committee 14/06/2024
Nominating Committee 17/06/2022
Compensation Committee Chair 14/06/2024
Yuko Yasuda

Yuko Yasuda

64 year

Compensation Committee 14/06/2024
Governance Committee 14/06/2024
Nominating Committee 14/06/2024
Toru Moriyama

Toru Moriyama

71 year

Compensation Committee 14/06/2024
Governance Committee 14/06/2024
Nominating Committee Chair 14/06/2024
Kanai Sawaji

Kanai Sawaji

67 year

Governance Committee 01/06/2024
Audit Committee Chair 01/06/2024
Hiroyuki Kato

Hiroyuki Kato

68 year

Audit Committee 17/06/2022
Kenta Takahashi

Kenta Takahashi

66 year

Audit Committee 14/06/2024
Haruo Naito

Haruo Naito

78 year

Director/Board Member 01/06/1983
Yasushi Okada

Yasushi Okada

67 year

Director/Board Member 01/06/2025

Latest Appointments: Eisai Co., Ltd.

11/23/11 Eisai exec who helped steer Alzheimer's drug approval to leave RE
11/23/11 Eisai exec who helped steer Alzheimer's drug approval to retire in July RE
05/23/05 Biogen splits R&D division ahead of key decision on Alzheimer's drug RE
10/22/10 Biogen hires former Sanofi head Viehbacher as CEO RE
25/22/25 Scynexis Names Ivor Macleod CFO MT
03/22/03 Biogen CEO to step down; drugmaker pulls back on Alzheimer's drug Aduhelm RE
10/22/10 H3 Biomedicine Inc Appoints Richard Woodman to its Board of Directors CI
More news

Former Officers and Directors: Eisai Co., Ltd.

Insider
Positions held
SinceUntil
Gary Bryan Hendler
Gary Bryan Hendler
Corporate Officer/Principal 01/06/2010 31/03/2026
Takashi Owa
Takashi Owa
Chief Tech/Sci/R&D Officer 01/06/2024 01/04/2025
Corporate Officer/Principal 01/04/2008 01/06/2024
Hideki Hayashi
Hideki Hayashi
Director/Board Member 01/06/2019 14/06/2024
Chief Tech/Sci/R&D Officer 01/06/2014 01/06/2019
Investor Relations Contact 01/06/2011 01/06/2012
Corporate Officer/Principal 01/06/2012 01/06/2014
Edward Stewart Geary
Edward Stewart Geary
Chief Tech/Sci/R&D Officer 01/10/2012 17/06/2022
Corporate Officer/Principal 01/01/2001 01/10/2012
Ryohei Yanagi
Ryohei Yanagi
Director of Finance/CFO 01/06/2015 17/06/2022
Investor Relations Contact 01/09/2009 01/04/2020
Toru Yamashita
Toru Yamashita
Director/Board Member 01/06/2014 -
Independent Dir/Board Member 01/06/2014 -
Ikuo Nishikawa
Ikuo Nishikawa
Director/Board Member 01/06/2014 -
Independent Dir/Board Member 01/06/2014 -
Patricia Robinson
Patricia Robinson
Director/Board Member 01/06/2013 -
Independent Dir/Board Member 01/06/2013 -
Graham Fry
Graham Fry
Director/Board Member 01/06/2012 -
Independent Dir/Board Member 01/06/2012 -
Osamu Suzuki
Osamu Suzuki
Director/Board Member 01/06/2012 -
Independent Dir/Board Member 01/06/2012 -
Kentaro Yoshimatsu
Kentaro Yoshimatsu
Chief Tech/Sci/R&D Officer 07/01/2010 30/09/2011
Corporate Officer/Principal 07/01/2010 16/09/2010
Michikazu Aoi
Michikazu Aoi
Director/Board Member 06/07/2011 -
Kiyochika Ota
Kiyochika Ota
Director/Board Member 01/06/2011 01/10/2015
Chairman 01/10/2015 -
Independent Dir/Board Member 01/06/2011 -
Soichi Matsuno
Soichi Matsuno
Corporate Officer/Principal 08/01/2010 -
President 07/01/2010 08/01/2010
Seiichiro Kobayashi
Seiichiro Kobayashi
Corporate Officer/Principal 18/06/2010 18/06/2010
Makoto Shiina
Makoto Shiina
Corporate Officer/Principal 07/01/2010 -
Folker Kindl
Folker Kindl
Corporate Officer/Principal 07/01/2010 -
Masanori Tsuno
Masanori Tsuno
Corporate Officer/Principal 07/01/2010 -
Kiyoshi Hasegawa
Kiyoshi Hasegawa
Corporate Officer/Principal 21/06/2011 -
Hidenobu Ando
Hidenobu Ando
Corporate Officer/Principal 07/01/2010 -
Ko-Yung Tung
Ko-Yung Tung
Director/Board Member 06/01/2010 -
Shinji Hatta
Shinji Hatta
Director-Back Office Operation 06/01/2010 06/01/2010
Director/Board Member 06/01/2010 18/06/2010
Tetsushi Ogawa
Tetsushi Ogawa
Director/Board Member 06/01/2010 -
Koichi Masuda
Koichi Masuda
Director/Board Member 16/09/2010 -
Lonnel Coats
Lonnel Coats
Corporate Officer/Principal 01/06/2010 -
President 08/07/2010 16/09/2010
Christina L Ahmadjian
Christina L Ahmadjian
Director/Board Member 06/01/2010 -
Tokuji Izumi
Tokuji Izumi
Director/Board Member 01/06/2010 -
Satoru Anzaki
Satoru Anzaki
Director/Board Member 06/01/2010 -
Junji Miyahara
Junji Miyahara
Director/Board Member 06/01/2010 -
Kimitoshi Yabuki
Kimitoshi Yabuki
Director/Board Member 06/01/2010 -
Norihiko Tanikawa
Norihiko Tanikawa
Chairman 06/01/2010 -
Ivan Cheung
Ivan Cheung
Corporate Officer/Principal 01/07/2009 -
Yasunobu Kai
Yasunobu Kai
Corporate Officer/Principal 01/04/1986 -
Junichi Asatani
Junichi Asatani
Comptroller/Controller/Auditor 01/04/2020 -
Compliance Officer 01/06/2014 01/04/2020
Corporate Officer/Principal 01/06/2012 01/06/2014
Hirokazu Kanai
Hirokazu Kanai
Comptroller/Controller/Auditor 01/04/1983 17/06/2016
Director/Board Member 17/06/2016 -
Investor Relations Contact 01/04/1983 -
Yuji Matsue
Yuji Matsue
Public Communications Contact 11/01/2010 26/01/2012
Corporate Officer/Principal 07/01/2010 -
Kazuo Hirai
Kazuo Hirai
Chief Tech/Sci/R&D Officer 20/09/2010 -
General Counsel 06/07/2011 26/01/2012
Corporate Officer/Principal 07/01/2010 20/09/2010
Hajime Shimizu
Hajime Shimizu
Director of Finance/CFO 01/06/2014 -
Corporate Officer/Principal 07/01/2010 01/06/2014
Takafumi Asano
Takafumi Asano
Corporate Officer/Principal 07/01/2010 -
Hideto Ueda
Hideto Ueda
Comptroller/Controller/Auditor 06/07/2011 26/01/2012
Compliance Officer 01/04/1980 -
General Counsel 06/07/2011 26/01/2012
Corporate Officer/Principal 26/01/2012 -
Noboru Naoe
Noboru Naoe
Director/Board Member 01/06/2014 -
Corporate Officer/Principal 01/04/1978 01/06/2014
Koji Nakamoto
Koji Nakamoto
Corporate Officer/Principal 01/04/1978 -
Yukio Akada
Yukio Akada
Corporate Officer/Principal 16/09/2010 -
Hideshi Honda
Hideshi Honda
Corporate Officer/Principal 07/01/2010 -
Akira Fujiyoshi
Akira Fujiyoshi
Director/Board Member 06/01/2010 -
Yutaka Tsuchiya
Yutaka Tsuchiya
Director/Board Member 01/06/2017 -
Corporate Officer/Principal 01/04/2001 01/06/2017
Norio Kano
Norio Kano
Director/Board Member 16/09/2010 -
Chief Tech/Sci/R&D Officer 07/01/2010 16/09/2010
Corporate Officer/Principal 07/01/2010 07/01/2010
Hideaki Matsui
Hideaki Matsui
Comptroller/Controller/Auditor 06/07/2011 23/01/2012
Director/Board Member 23/01/2012 -
Director of Finance/CFO 07/01/2010 23/01/2012
Corporate Officer/Principal 07/01/2010 07/01/2010
Hiroyuki Mitsui
Hiroyuki Mitsui
Director/Board Member 06/01/2010 -
Corporate Officer/Principal 07/01/2010 -
Nobuo Deguchi
Nobuo Deguchi
Director/Board Member 01/06/2012 -
Human Resources Officer 07/01/2010 07/01/2010
Public Communications Contact 07/01/2010 07/01/2010
General Counsel 11/01/2010 23/07/2012
Corporate Officer/Principal 07/01/2010 07/01/2010
Kyoko Tezuka
Kyoko Tezuka
Public Communications Contact 10/07/2009 -
Masaharu Ito
Masaharu Ito
Corporate Officer/Principal - -
Akiyoshi Uchiyama
Akiyoshi Uchiyama
Director/Board Member - -
Kenji Matsumae
Kenji Matsumae
Corporate Officer/Principal - -
Steven A. Jacobs
Steven A. Jacobs
Chief Operating Officer - -
President - -
Miroslav S. Ravic
Miroslav S. Ravic
Corporate Officer/Principal - -
Kenji Toda
Kenji Toda
Public Communications Contact 06/07/2011 26/01/2012
General Counsel 07/01/2010 16/09/2010
Corporate Officer/Principal 07/01/2010 07/01/2010
Toyoji Naito
Toyoji Naito
Founder 01/11/1936 -

Age distribution of managers

Parity Men Women

Male21
Female5

Of which Executive Committee

Male10
Female1

Of which Directors

Male8
Female2

Revisions

Recommandations analystes
-
Évolution recommandations analystes 1 an
-
Évolution recommandations analystes 4 mois
-
Objectif analystes
-
Évolution objectif analystes 1 an
-
Évolution objectif analystes 4 mois
-
ESG MSCI

ESG MSCI

Environnement
Social
Gouvernance
Polémique
Controverses Ethiques
No
Controverses sur les droits de l'Homme
No
Controverses Subventions fiscales
No
Conforme à la finance Islamique
No

Company Profile

Logo Eisai Co., Ltd.
Eisai Co Ltd is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
Employees
10,917
Sector
Pharmaceuticals
Calendar
Earnings release - Q1 2027
More about the company

Departures of Key Persons

Yasuhiko Katoh
-
Yasuhiko Katoh

Chairman

01/06/2018 -

Kiyochika Ota
-
Kiyochika Ota

Chairman

01/10/2015 -

Norihiko Tanikawa
-
Norihiko Tanikawa

Chairman

06/01/2010 -

  1. Stock Market
  2. Stocks
  3. 4523 Stock
  4. Company Eisai Co., Ltd.
  5. Governance
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition